Inify Laboratories AB
INIFY
Overview
Corporate Details
- ISIN(s):
- SE0017486103
- LEI:
- 549300306YYJ3BX3VB98
- Country:
- Sweden
- Address:
- Scheeles väg 3, 171 65 Solna
- Website:
- https://www.inify.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Inify Laboratories AB provides digital pathology services for cancer diagnostics.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-21 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Inify Laboratories AB (publ) – summary of Annual General Meeting
|
English | 180.9 KB | |
| 2025-05-21 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Inify Laboratories AB (publ) – kommuniké från årsstämma
|
Swedish | 172.6 KB | |
| 2025-05-21 06:00 |
Declaration of Voting Results & Voting Rights Announcements
Inify Laboratories AB (publ) - summary of Annual General Meeting
|
English | 180.9 KB | |
| 2025-05-21 06:00 |
Declaration of Voting Results & Voting Rights Announcements
Inify Laboratories AB (publ) - kommuniké från årsstämma
|
Swedish | 172.6 KB | |
| 2025-05-21 06:00 |
Declaration of Voting Results & Voting Rights Announcements
Inify Laboratories AB (publ) - summary of Annual General Meeting
|
English | 3.4 KB | |
| 2025-05-21 06:00 |
Declaration of Voting Results & Voting Rights Announcements
Inify Laboratories AB (publ) - kommuniké från årsstämma
|
Swedish | 3.4 KB | |
| 2025-04-30 08:00 |
Quarterly Report
|
Swedish | 1.3 MB | |
| 2025-04-30 08:00 |
Interim Report
|
English | 1.3 MB | |
| 2025-04-30 06:00 |
Interim Report
Inify Laboratories: Continued strong growth - construction and establishment in…
|
English | 1.3 MB | |
| 2025-04-30 06:00 |
Quarterly Report
Inify Laboratories: Fortsatt stark tillväxt - uppbyggnad och etablering i Storb…
|
Swedish | 1.3 MB | |
| 2025-04-30 06:00 |
Interim Report
Inify Laboratories: Fortsatt sterk vekst - bygging og etablering i Storbritannia
|
English | 1.3 MB | |
| 2025-04-30 06:00 |
Earnings Release
Inify Laboratories: Continued strong growth - construction and establishment in…
|
English | 3.4 KB | |
| 2025-04-30 06:00 |
Earnings Release
Inify Laboratories: Fortsatt stark tillväxt - uppbyggnad och etablering i Storb…
|
Swedish | 3.4 KB | |
| 2025-04-30 06:00 |
Earnings Release
Inify Laboratories: Fortsatt sterk vekst - bygging og etablering i Storbritannia
|
Norwegian | 3.3 KB | |
| 2025-04-16 06:00 |
Annual Report
Inify Laboratories - Årsredovisning 2024
|
Swedish | 3.1 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-29 | Olof Sandén | Other | Buy | 10,000 | 44,800.00 SEK |
| 2025-01-27 | Olof Sandén | Other | Buy | 6,840 | 28,659.60 SEK |
| 2023-07-05 | Magne Jordanger | Other | Buy | 650,000 | 6,500,000.00 EUR |
| 2022-08-19 | Magne Jordanger | Other | Buy | 336,950 | 2,560,820.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
GenSight Biologics S.A. | France | SIGHT | |
|
Gentian Diagnostics ASA | Norway | GENT | |
|
Genus PLC | United Kingdom | GNS | |
|
Grace Breeding Ltd. | Israel | GRAC | |
|
Group 107 Ltd. | Israel | G107 | |
|
Guard Therapeutics International AB | Sweden | GUARD | |
|
Gubra A/S | Denmark | GUBRA | |
|
Hadasit Bio Holding Ltd. | Israel | HDST-M | |
|
Hansa Biopharma | Sweden | HNSA | |
|
HEMOGENYX PHARMACEUTICALS PLC | United Kingdom | HEMO |